NK Cell
5 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Phase1 Clinical Trial Evaluating Locoregional Delivery Of Engineered NK Cells Containing IL13Ra And EGFvIII Chimeric Antigen Receptor (CAR), IL-21 Secretion And Deleted TGF-BetaR2 And NR3C1 In Recurrent Glioblastoma (NCT07579208) | M.D. Anderson Cancer Center | 2026-10-24 |
| A Phase I Single-arm Clinical Study of Donor NK Cells Infusion Combined With Low-dose Interleukin-2 in the Treatment of Acute Myeloid Leukemia Relapse After Allogeneic Hematopoietic Stem Cell Transplantation. (NCT06641648) | Peking University First Hospital | 2025-11-01 |
| CD123-CD16-NK Cells Immunotherapy for AML (NCT06835140) | Chunji Gao | 2025-02-21 |
| Safety and Efficacy of Autologous NK Cell Adjuvant Therapy for Relapsed/Refractory Non-Hodgkin's B-cell Lymphoma (NCT05909098) | Xiangyang No.1 People's Hospital | 2023-07-01 |
| Anti-PD-1 Antibody Combined With Autologous DC and NK Cells in the Treatment of Digestive Carcinoma (NCT05461235) | China Medical University, China | 2022-07-15 |
Track NK Cell automatically
Every clearance here is in the API, with alerts when new ones post.